We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

BRIEF Bendamustine and Rituximab In Elderly Follicular (BRIEF)

This study has been terminated.
(Treament with rituximab during maintenance phase was stoped, according to DSMC recommendations, since 3 cases of deaths occured.)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01313611
First Posted: March 14, 2011
Last Update Posted: September 8, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
The Lymphoma Academic Research Organisation
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: December 2017
  Primary Completion Date: October 2012 (Final data collection date for primary outcome measure)